CARDIOVASCULAR

WHY CHOOSE ECLEVAR ?

Board-certified cardiologists, vascular surgeons, and interventional radiologists demonstrating extensive clinical trial experience needed for safety and efficacy assessments surrounding cardiovascular diseases, both qualitative and quantitatively

In- house registered vascular imaging technologists (RVTs) and echocardiographers (ECHO technologists) with widespread knowledge in qualifying sites with customized and advanced data acquisition protocol for cardiovascular studies, and experience in performing and assessing cardiac and vascular imaging in clinical trials

Imaging project managers specializing in managing cardiovascular disease trials, as well as the respective analyses and quality checks for the needed imaging assessments.

IN ORDER TO ENSURE SUCCESS, WE HELP OUR CLIENTS :

Effectively plan and conduct cardiovascular studies for drug/device and cardiac safety

Efficiently conduct large cardiovascular endpoint trials that demand rigorous safety requirements

Seamlessly integrate cardiovascular trials with metabolic/endocrinology projects

  • NEWS
  • EVENTS
  • WHITE PAPERS
EU ISSUES Q&A DOCUMENT TO PROVIDE FURTHER ANALYSIS OF POTENTIAL NO-DEAL BREXIT

Twelve (12) months ago, the EU Commission published a Notice to Stakeholders, “Withdrawal of the United Kingdom and EU Rules in the Field of Industrial Products,”Read More..

JOIN ECLEVAR AT MEDTEC JAPAN

ECLEVAR invites you to meet with us at MedTec Japan in Tokyo, Japan on 18-20 April.